PPA
IDXX icon

Pacific Point Advisors’s Idexx Laboratories IDXX Stock Holding History

Pacific Point Advisors’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$971K Sell
1,844
-541
-23% -$303K 0.44% 63
2026
Q1 		$1.34M Buy
2,385
+5
+0.2% +$3.21K 0.71% 43
2025
Q4 		$1.61M Sell
2,380
-102
-4% -$69.5K 0.86% 28
2025
Q3 		$1.59M Sell
2,482
-1,154
-32% -$700K 0.93% 30
2025
Q2 		$1.95M Buy
3,636
+179
+5% +$85.6K 1.06% 16
2025
Q1 		$1.45M Buy
3,457
+274
+9% +$119K 0.81% 33
2024
Q4 		$1.48M Buy
+3,183
New +$1.4M 0.9% 19

Other funds holding IDXX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Pacific Point Advisors's IDXX Position: Q2 2026 in Review

Pacific Point Advisors reduced its Idexx Laboratories (IDXX) stake by 23% in Q2 2026, selling an estimated $303K and leaving 1,844 shares worth $971K. The position accounts for 0.44% of the portfolio, ranked #63.

Pacific Point Advisors first reported a position in IDXX in Q4 2024 and has held it in 7 quarters since. The position peaked at $1.95M in Q2 2025. 1,302 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Pacific Point Advisors held 1,844 shares of Idexx Laboratories worth $971K as of Q2 2026.
  • Pacific Point Advisors sold 541 Idexx Laboratories shares in Q2 2026, an estimated $303K.
  • Idexx Laboratories made up 0.44% of Pacific Point Advisors's portfolio in Q2 2026, its #63 holding.
  • Pacific Point Advisors first reported a position in Idexx Laboratories in Q4 2024 and has held it in 7 quarters since.
  • Pacific Point Advisors's Idexx Laboratories position peaked at $1.95M in Q2 2025.
  • 1,302 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Pacific Point Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.